CN Patent

CN111388657B — 一种包含比伐芦定的药物组合物及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2023-04-07 · 3y expired

What this patent protects

本发明涉及一种包含比伐芦定的药物组合物及其制备方法。具体而言，该药物组合物包含比伐芦定和赋形剂，所述赋形剂包含氨基酸。该组合物具备良好的流动性，稳定性优异，可以更好地应用于临床。

USPTO Abstract

本发明涉及一种包含比伐芦定的药物组合物及其制备方法。具体而言，该药物组合物包含比伐芦定和赋形剂，所述赋形剂包含氨基酸。该组合物具备良好的流动性，稳定性优异，可以更好地应用于临床。

Drugs covered by this patent

Patent Metadata

Patent number
CN111388657B
Jurisdiction
CN
Classification
—
Expires
2023-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.